An Ongoing Debate: Are the Patients Receiving Angiotensin-Converting Enzyme Inhibitors and/or Angiotensin Receptor Blockers More Susceptible to COVID-19?


Yılmaz S., Elaldı N., Ertin H.

Anadolu Kliniği Tıp Bilimleri Dergisi, vol.25, no.1, pp.79-84, 2020 (Peer-Reviewed Journal)